He knew that they could help prevent the disease. Scientists know that in breast cancer cases a gene called cox2 can lead to tumors. The drug celebrex is designed specifically to inhibit cox2. In laboratory testing, it showed a striking reduction in not only the rate of breast cancer but also in the size of the tumor. We feel it can be taken and moved into clinical trials in humans very quickly to see if it has a significant impact on either the therapy or the prevention of breast cancer and perhaps other malignancies.
Breast cancer is the most commonly diagnosed cancer in the United States.
It kills nearly 44,000 women every year. Doctors are hoping their early findings will hold up in the long run. They want to start bringing those numbers down. Researchers are now lobbying to test celebrex on cancer patients. This site is best viewed in Internet Explorer 4.0 or higher and Netscape 4.0 and higher.